Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen up 15 pct year-to-date; hope for blockbuster osteoporosis drug defends against declines
Yahoo/AP
Tuesday, October 21, 2008 - 9:30am
tags:
Novartis & Biotechs: ‘I Don’t Think We’ve Seen the Trough’
WSJ Online
Tuesday, October 21, 2008 - 9:29am
tags:
Foolish Forecast: Will Pfizer Flounder Through Another Quarter?
Motley Fool
Tuesday, October 21, 2008 - 9:28am
tags:
Takeda Rises as Buyback Plan Outweighs Drug Delays
Bloomberg
Tuesday, October 21, 2008 - 9:27am
tags:
Novartis CEO Seeks Biotechs Needing Funds, Investors
Bloomberg
Tuesday, October 21, 2008 - 9:26am
tags:
Actavis plays down sale rumours
FT.com
Monday, October 20, 2008 - 11:33am
tags:
Biogen works to stave off proxy fights
Fierce Pharma
Monday, October 20, 2008 - 11:32am
tags:
Drug stocks move forward with broader market
Marketwatch
Monday, October 20, 2008 - 11:30am
tags:
[video]TheStreet.com BioTalk: Big-Cap Breakdown
The Street.com
Monday, October 20, 2008 - 11:22am
tags:
Don't Get Burned by the Next Cell Genesys
The Street.com
Monday, October 20, 2008 - 10:45am
tags:
FDA delays approval of Forest's antidepressant milnacipran
Marketwatch
Monday, October 20, 2008 - 10:38am
tags:
Gilead Offers Opportunities
Yahoo/Zacks.com
Monday, October 20, 2008 - 10:37am
tags:
Ten Highest Yielding Pharma Stocks
Seeking Alpha
Monday, October 20, 2008 - 10:36am
tags:
The Vytorin Limbo: Going Lower All The Time
Pharmalot
Monday, October 20, 2008 - 9:51am
tags:
Pfizer, UCB, U.K. government team up for R&D project
Marketwatch
Monday, October 20, 2008 - 9:49am
tags:
Novartis A Picture Of Health (For Now)
Forbes
Monday, October 20, 2008 - 9:48am
tags:
Novartis Earnings Rise 32%
The Street.com
Monday, October 20, 2008 - 9:48am
tags:
Novartis Changes Division Heads, Plans U.S. Job Cuts
Bloomberg
Monday, October 20, 2008 - 9:42am
tags:
Genentech Says Avastin Study in Early Colon Cancer to Go Ahead
Bloomberg
Monday, October 20, 2008 - 9:40am
tags:
How Will FDA Ruling Affect Eli Lilly's Effient?
Seeking Alpha
Sunday, October 19, 2008 - 1:00pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.